<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04039594</url>
  </required_header>
  <id_info>
    <org_study_id>2019027X</org_study_id>
    <nct_id>NCT04039594</nct_id>
  </id_info>
  <brief_title>Outcomes of Patients With Venoarterial Extracorporeal Membrane Oxygenation</brief_title>
  <official_title>Outcomes of Patients With Venoarterial Extracorporeal Membrane Oxygenation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Beijing Anzhen Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Beijing Anzhen Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Venoarterial extracorporeal membrane oxygenation (VA ECMO)—also referred to as extracorporeal
      life support—is a form of temporary mechanical circulatory support and simultaneous
      extracorporeal gas exchange. The objective of this observational, cohort study is to evaluate
      the short-term and long-term outcomes of patients with VA ECMO.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 1, 2019</start_date>
  <completion_date type="Anticipated">July 31, 2025</completion_date>
  <primary_completion_date type="Anticipated">July 31, 2024</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>1 Year</target_duration>
  <primary_outcome>
    <measure>All-cause mortality</measure>
    <time_frame>30 days</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>All-cause mortality</measure>
    <time_frame>365 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of successful weaning from ECMO</measure>
    <time_frame>30 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ECMO-related complications</measure>
    <time_frame>30 days</time_frame>
    <description>Bleeding requiring transfusion or surgery, stroke, sepsis, limb ischemia requiring intervention, system or cannula change</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Other complications</measure>
    <time_frame>30 days</time_frame>
    <description>Acute renal failure, ulcer bleeding, pneumonia, sepsis</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration stay at ICU and hospital</measure>
    <time_frame>365 days</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">500</enrollment>
  <condition>Cardiogenic Shock</condition>
  <condition>Cardiac Arrest</condition>
  <arm_group>
    <arm_group_label>ECMO</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>VA ECMO</intervention_name>
    <description>VA ECMO for cardiopulmonary support</description>
    <arm_group_label>ECMO</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients receiving VA ECMO for cardiopulmonary support
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Patients receiving VA ECMO for cardiopulmonary support

        Exclusion Criteria:

        Refusal of consent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Xiaotong Hou, MD., PhD.</last_name>
    <phone>8610 64456631</phone>
    <email>xt.hou@ccmu.edu.cn</email>
  </overall_contact>
  <location>
    <facility>
      <name>Center for Cardiac Intensive Care, Beijing Anzhen Hospital, Capital Medical University</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100029</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Xiaotong Hou, MD., PhD.</last_name>
      <phone>8610 64456631</phone>
      <email>xt.hou@ccmu.edu.cn</email>
    </contact>
    <investigator>
      <last_name>Xiaotong Hou, MD., PhD.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>August 2019</verification_date>
  <study_first_submitted>July 30, 2019</study_first_submitted>
  <study_first_submitted_qc>July 30, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">July 31, 2019</study_first_posted>
  <last_update_submitted>August 4, 2019</last_update_submitted>
  <last_update_submitted_qc>August 4, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">August 6, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Beijing Anzhen Hospital</investigator_affiliation>
    <investigator_full_name>Xiaotong Hou</investigator_full_name>
    <investigator_title>Chief, Center for Cardiac Intensive Care</investigator_title>
  </responsible_party>
  <keyword>extracorporeal life support, extracorporeal membrane oxygenation, cardiogenic shock, cardiac arrest</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Arrest</mesh_term>
    <mesh_term>Shock, Cardiogenic</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

